TGFBR1 and non-small cell lung carcinoma: Therefore, miR-181b could regulate cell proliferation and cisplatin-chemosensitivity and metastatic capability by targeting TGFβR1/Smad signal pathway, suggesting a candidate method for NSCLC treatment.